The impact of an electronic hospital system on therapeutic drug monitoring

Australian hospitals have undergone a transformation with both a review and expansion of traditional roles of healthcare professionals and the implementation of an ieMR. The implementation of an ieMR brings large scale organizational change within the health system especially for staff with direct patient contact. This is changing the future of healthcare and the roles of healthcare professionals. There is minimal research on the impact of these electronic systems on the people and processes required to realise the improvements in patient care such as therapeutic drug monitoring (TDM) and the role of the pharmacist within the TDM process. The literature has discussed the use of computerised programs to assist with the interpretation of results and calculating of doses but the impact of an ieMR on the TDM process has not been discussed. This study undertook a retrospective analysis at an Australian tertiary hospital to investigate the impact of a digital hospital system on TDM within the facility.

• Publication year

  2021

• Venue

  Journal of Clinical Pharmacy and Therapeutics

• Publication date

  2021-07-30

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/jcpt.13497PMID 34328229
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Steps to Therapeutic Drug Monitoring: A Structured Approach Illustrated With Imatinib

  2020cited by this paper
• The impact of implementing a hospital electronic prescribing and administration system on clinical pharmacists’ activities - a mixed methods study

  2019cited by this paper
• Time to give up on expanded scope of practice

  2018cited by this paper
• Reference ranges for antiepileptic drugs revisited: a practical approach to establish national guidelines

  2018cited by this paper
• Does extended CPOE use reduce patient length of stay?

  2017cited by this paper
• A randomized trial of a community-based approach to dyslipidemia management

  2016cited by this paper
• Economic impact of electronic prescribing in the hospital setting: A systematic review

  2016cited by this paper
• Impact of a Clinical Solid Organ Transplant Pharmacist on Tacrolimus Nephrotoxicity, Therapeutic Drug Monitoring, and Institutional Revenue Generation in Adult Kidney Transplant Recipients

  2016cited by this paper
• Community pharmacist targeted screening for chronic kidney disease

  2016cited by this paper
• The Effectiveness of Pharmacist Interventions on Cardiovascular Risk: The Multicenter Randomized Controlled RxEACH Trial.

  2016cited by this paper
• Evaluation of pharmacist-based compared to doctor-based anticoagulation management in Qatar.

  2016cited by this paper
• The effectiveness of computerized order entry at reducing preventable adverse drug events and medication errors in hospital settings: a systematic review and meta-analysis

  2014cited by this paper
• Pharmacist intervention for glycaemic control in the community (the RxING study)

  2013cited by this paper
• Impact of a Pharmacist-Directed Anticoagulation Service on the Quality and Safety of Heparin-Induced Thrombocytopenia Management

  2011cited by this paper
• The Impact of eHealth on the Quality and Safety of Health Care: A Systematic Overview

  2011cited by this paper
• Current Status of Therapeutic Drug Monitoring in Australia and New Zealand: A Need for Improved Assay Evaluation, Best Practice Guidelines, and Professional Development

  2010cited by this paper
• Overview of Therapeutic Drug Monitoring

  2009cited by this paper
• The impact of computerized physician medication order entry in hospitalized patients - A systematic review

  2008cited by this paper
• The neurobiology of antiepileptic drugs

  2004cited by this paper
• Evaluation of Therapeutic Drug Monitoring Services and Comparison of Two Models of Service Provision

  2004cited by this paper
• Best practice in therapeutic drug monitoring.

  2001cited by this paper
• Best practice in therapeutic drug monitoring.

  2001cited by this paper
• Impact of goal-oriented and model-based clinical pharmacokinetic dosing of aminoglycosides on clinical outcome: a cost-effectiveness analysis.

  1999cited by this paper
• ASHP statement on the pharmacist's role in clinical pharmacokinetic monitoring.

  1998cited by this paper

• Insights on antifungal therapeutic drug monitoring from infectious diseases physicians and hospital‐based pharmacists: A focus group analysis

  2025cites this paper
• Pharmacists' views on the implementation of therapeutic drug monitoring in oncology

  2025cites this paper
• Economic evaluations of therapeutic drug monitoring interventions in acute hospital‐based settings: A systematic review

  2024cites this paper
• Optimizing vancomycin therapeutic drug monitoring compliance in pediatric oncology: towards personalized medication management.

  2024cites this paper
• The Effects of Digital Transformation on Healthcare Business Models in Zimbabwe: Perceptions and Implications

  2024cites this paper
• Pharmacist-Managed Therapeutic Drug Monitoring Programs within Australian Hospital and Health Services—A National Survey of Current Practice

  2022cites this paper
• The Development, Implementation, and Evaluation of a Pharmacist-Managed Therapeutic Drug Monitoring (TDM) Service for Vancomycin—A Pilot Study

  2022cites this paper
• Machine learning advances the integration of covariates in population pharmacokinetic models: Valproic acid as an example

  2022cites this paper